Sumanirole (PNU-95666) is a highly selective D2 receptor full agonist the first of its kind to be discovered. It was developed for the treatment of Parkinson’s disease and restless leg syndrome. While it has never been approved for medical use it is a highly valuable tool compound for basic research to identify neurobiological mechanisms that are based on a dopamine D2-linked (vs. D1 D3 D4 and D5-linked) mechanism of action.
This page contains content from the copyrighted Wikipedia article "Sumanirole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
